Navigation Links
Cumberland Pharmaceuticals Reports First Quarter 2011 Financial Results
Date:5/4/2011

ess release contains forward-looking statements, which are subject to certain risks and reflect Cumberland's current views on future events based on what it believes are reasonable assumptions. No assurance can be given that these events will occur. As with any business, all phases of Cumberland's operations are subject to factors outside its control, and any one or combination of these factors could materially affect Cumberland's results of operations. These factors include market conditions, competition, an inability of manufacturers to produce Cumberland's products on a timely basis or a failure of manufacturers to comply with regulations applicable to pharmaceutical manufacturers, maintaining an effective sales and marketing infrastructure and other factors discussed in the Company's Form 10-K filed with the SEC on March 11, 2011. There can be no assurance that results anticipated by the Company will be realized or that they will have the expected effects. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date hereof. The Company does not undertake any obligation to publicly revise these statements to reflect events after the date hereof.

CUMBERLAND PHARMACEUTICALS INC. AND SUBSIDIARIESCondensed Consolidated Balance Sheets(Unaudited)March 31,December 31,20112010ASSETSCurrent assets:Cash and cash equivalents

$  65,958,844$
5,893,970Accounts receivable, net of allowances

5,145,5905,145,494Inventories

7,822,8727,683,842Other current assets

2,174,6382,315,536Total current assets

81,101,94481,038,842Property and equipment, net

1,196,5161,220,010Intangible assets, net

7,269,6497,427,223Other assets

2,006,9402,367,979Total assets

$  91,575,049$
92,054,054LIABILITIES AND EQUITYCurrent liabilities:Current portion of long-term debt

$
2,666,668$
2,666,668Accounts payable

2,170,9292,124,654Other current liabi
'/>"/>

SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Cumberland Pharmaceuticals to Announce First Quarter 2011 Financial Results on May 4, 2011
2. Cumberland Pharmaceuticals Announces New Product Addition With Hepatoren™ (ifetroban) Injection
3. Cumberland Pharmaceuticals Appoints Rick S. Greene as Vice President, Finance & Accounting
4. Cumberland Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results
5. Cumberland Pharmaceuticals Appoints Tan Cheow Choon as Director of International Business
6. Cumberland Pharmaceuticals to Announce 2010 Financial Results on March 8, 2011
7. Cumberland Pharmaceuticals Receives FDA Approval for New Formulation of Acetadote
8. Cumberland Pharmaceuticals Announces Joey Jacobs Has Joined Its Board of Directors
9. Cumberland Pharmaceuticals Announces Voluntary Recall of Acetadote® Vials
10. Cumberland Pharmaceuticals Reports Third Quarter 2010 Financial Results
11. Cumberland Pharmaceuticals to Announce Third Quarter 2010 Financial Results on November 11, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... July 30, 2015  Lannett Company, Inc. (NYSE: ... at the Canaccord Genuity 35th Annual Growth Conference on ... the InterContinental Boston Hotel.  A webcast ... .  Listeners are encouraged to visit the web site ... the presentation to register, download and install any necessary ...
(Date:7/30/2015)... , July 30, 2015  Arena Pharmaceuticals, Inc. ... a conference call and webcast at 5:00 p.m. Eastern ... 2015, to discuss second quarter 2015 financial results and ... results after the NASDAQ Global Select Market closes that ... by dialing 877.643.7155 for domestic callers and 914.495.8552 for ...
(Date:7/30/2015)...  Cardinal Health today reported fourth-quarter fiscal year ... 20 percent, and non-GAAP diluted earnings per share ... of 20 percent. Non-GAAP operating earnings increased 33 ... operating earnings increased 44 percent to $558 million, ... percent to $0.88. Fiscal year 2015 ...
Breaking Medicine Technology:Arena Pharmaceuticals to Host Second Quarter 2015 Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 5 2Arena Pharmaceuticals to Host Second Quarter 2015 Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 5 3Arena Pharmaceuticals to Host Second Quarter 2015 Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 5 4Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 2Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 3Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 4Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 5Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 6Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 7Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 8Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 9Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 10Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 11Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 12Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 13Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 14Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 15Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 16Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 17Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 18Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 19Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 20Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 21Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 22Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 23Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 24Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 25Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 26Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 27Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 28Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 29Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 30Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 31Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 32Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 33
... for first Albuferon(R) Phase 3 trial announced in December 2008; ... - Phase 3 trials of darapladib for cardiovascular disease and ... - $106 million of convertible debt repurchased ... expected to grow to $250 million; at least $150 million ...
... Broadens Power of Current Genetic Discovery Techniques -PHILADELPHIA, Feb. 26 ... contribute to a complex disease is like searching in the ... much smaller than others, often blending into the background, and ... some needles are linked to each other by fine threads, ...
Cached Medicine Technology:Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments 2Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments 3Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments 4Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments 5Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments 6Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments 7Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments 8Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments 9Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments 10The Children's Hospital of Philadelphia: New Gene-Searching Method Uncovers Possible New Targets for Crohn's Disease Drugs 2The Children's Hospital of Philadelphia: New Gene-Searching Method Uncovers Possible New Targets for Crohn's Disease Drugs 3The Children's Hospital of Philadelphia: New Gene-Searching Method Uncovers Possible New Targets for Crohn's Disease Drugs 4
(Date:7/30/2015)... ... July 30, 2015 , ... OncLive®’s ... UCLA’s Jonsson Comprehensive Cancer Center (JCCC) mutually agreed to collaborate on ... OncLive’s editorial and marketing groups will help spread the news about the center’s ...
(Date:7/30/2015)... , ... July 30, 2015 , ... Using the latest ... and teach people more effective ways to prevent and manage major depression. , “Suicide ... fast enough, so people fall through the cracks and die needlessly everyday,” says Walker. ...
(Date:7/30/2015)... ... July 30, 2015 , ... Quintessa Medical Spa is happy to offer ... treatment designed specifically for the elimination of excess tissue under the chin, referred ... the state of Wisconsin to offer this innovative treatment. , Developed by Kythera Biopharmaceuticals, ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... Earns National Cancer Institute Designation , The Tisch Cancer Institute (TCI) at the ... Institute (NCI)-designated cancer center. TCI joins an elite group of 69 cancer institutions ...
(Date:7/30/2015)... ... July 30, 2015 , ... Author Dr. Raul Llanos ... health in his new self-help book, “ Consciously Healing our Webs of Health, Wellbeing, ... simple message: “If we take responsibility for ourselves, we can create better realities.” His ...
Breaking Medicine News(10 mins):Health News:UCLA Jonsson Comprehensive Cancer Center Teams with OncLive® as a Strategic Alliance Partner 2Health News:UCLA Jonsson Comprehensive Cancer Center Teams with OncLive® as a Strategic Alliance Partner 3Health News:UCLA Jonsson Comprehensive Cancer Center Teams with OncLive® as a Strategic Alliance Partner 4Health News:Happiness Expert Develops Pioneering Online Tools for Sufferers of Major Depression, and Who may be Suicidal 2Health News:Happiness Expert Develops Pioneering Online Tools for Sufferers of Major Depression, and Who may be Suicidal 3Health News:Quintessa MedSpa Offers Nonsurgical Double-chin Elimination 2Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 2Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 3Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 4Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 5Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 6Health News:New book by Dr. Raul Llanos: ‘The power to change is within’ 2Health News:New book by Dr. Raul Llanos: ‘The power to change is within’ 3
... Places where you ... porn site. , ... -- The Phoenix Forum is Thursday, April 8th through Saturday, the 10th at the Tempe Mission ... to improve your traffic and revenue stream in 2010 and beyond. "I can,t wait to catch ...
... ... and positioning of healthcare technology solutions. , ... (PRWEB) April 8, 2010 -- CapSite™ Consulting, ... comparisons of contracts and proposals for Healthcare IT, Imaging Equipment and Medical Device ...
... ... a period of absence. , ... (PRWEB) April 8, 2010 -- As budget-conscious companies look for creative ways to reduce employee ... has become a quickly growing trend. Billed as a progressive workplace benefit, PRtW is designed ...
... Steven ... ... Tonkinson & Associates financial planning firm, will depart April 15th to deliver shelter and clean ... tents and life-saving supplies for up to 100,000 earthquake survivors in Haiti. Around 10,000 ...
... 2010) Educating individuals about the costs of healthcare could ... the healthcare system, report policy researchers at Tufts University School ... study is the first to assess the effect of knowledge ... by individuals out of total healthcare costs) on self-reported and ...
... ... ... of April, AthletiCo Physical Therapy and Occupational Therapy celebrates National Occupational Therapy ... the premier specialists in treating upper extremity diagnoses. , , , , ,Occupational/hand ...
Cached Medicine News:Health News:Jay Servidio President Teleteria Appearances To Discuss The Porn Business This Week 2Health News:CapSite™ Provides Detailed Transparency on Healthcare Technology Purchases 2Health News:Intellicate Announces New “Phased Return to Work” (PRtW) Service 2Health News:Intellicate Announces New “Phased Return to Work” (PRtW) Service 3Health News:Miami Businessman Heads to Haiti to Deliver ShelterBoxes 2Health News:Educate individuals to prevent sky-rocketing health care costs 2Health News:AthletiCo Offers Occupational Therapy Tips for Managing Arthritis 2Health News:AthletiCo Offers Occupational Therapy Tips for Managing Arthritis 3
Used with Temporary Myocardial Heartwires....
Implantable medical grade silicone end cap for insulation and sealing protection of 5 mm or 3.2 mm connectors....
... InSync ICD cardiac resynchronization and ICD device ... (BOL). The unit's RV only sensing provides ... and LV depolarizations, eliminating this cause of ... to LV separation for optimized hemodynamics. Proven ...
... The Guidant Contak Renewal 3 ... ventricular tachyarrhythmia therapy and cardiac ... right ventricular (RV) and left ... Designed to reduce irregular ventricular ...
Medicine Products: